Page 1

News Release Mirion Technologies Announces Results for the Fiscal Quarter Ended September 30 , 2021 GAAP revenues for the fiscal quarter ended September 30 , 2021 increased 26 % to $ 144.3 million , compared to $ 114.6 million in the prior - year period GAAP net loss for the quarter increased 15.8 % to ( $ 46.7 ) million Adjusted revenues up 29 % to $ 148 million ; Adjusted EBITDA up 28 % to $ 30.9 million ● Larry Kingsley joins Mirion Technologies as Chairman of the Board after successful completion of business combination with GS Acquisition Holdings Corp II Mirion Technologies trading on the New York Stock Exchange under the ticker symbol MIR following successful business combination ● MIRION TECHNOLOGIES ● Atlanta , GA - November 12 , 2021 - Mirion Technologies , Inc. ( " Mirion " ) ( NYSE : MIR ) , a global provider of detection , measurement , analysis and monitoring solutions to the medical , nuclear , defense , and research end markets , today announced results for the quarter ended September 30 , 2021 for Mirion Technologies ( TopCo ) , Ltd ( " Legacy Mirion " ) . Legacy Mirion was the parent company for the Mirion business before the business combination with GS Acquisition Holdings Corp II ( " GSAH " ) which closed on October 20 , 2021 . Revenue for the quarter increased 26 % to $ 144.3 million from $ 114.6 million in the prior - year period and adjusted revenues in the quarter increased 29 % to $ 148.0 million from $ 114.6 million in the prior year period . The increase in revenue was largely driven by acquisitions within the company's Medical segment , partially offset by lower revenue growth in the Industrial segment . Organic growth for the quarter ending September 30 , 2021 was ( 0.1 % ) versus 8.5 % in the prior - year comparable period . Organic growth for the nine - months ended September 30 , 2021 was 4.0 % versus 3.3 % for the prior - year comparable period . Income ( loss ) from operations for the quarter was a loss of $ 8.9 million compared to income of $ 4.6 million for the prior period . Income from operations as a percentage of revenue was negative 6.2 % compared to a positive 4.0 % in the prior year quarter . Adjusted EBITDA was $ 30.9 million , compared to the prior - year period of $ 24.0 million . Adjusted EBITDA margins as a percentage of adjusted revenue remain flat over the period as the incremental gross margin expansion was offset by higher operating expenses primarily related to the product mix in the medical acquisitions , investments in growth focused R & D and incremental corporate expenses related to public company requirements . For the Medical segment , revenue for the quarter was $ 52.0 million and adjusted revenue was $ 55.7 million , a 155 % and 173 % increase , respectively , over the prior - year period driven by acquisitions . For the Industrial segment , revenue and adjusted revenue for the quarter was $ 92.3 million , compared to $ 94.2 million in the prior year . Thomas Logan , Mirion's CEO commented , " Our team delivered an outstanding result for the quarter ended September 30 , 2021. We performed well in a challenging and dynamic environment and are well sitioned to execute on the broad - based demand for our luct portfolio . We have seen a number of supply chain challenges and logistical delays throughout the COVID pandemic , but have been generally successful in mitigating by supporting suppliers in sourcing critical components , extending our sales and operational planning forecast windows , and leaning on our strong strategic inventory positions . This is an area of significant focus for me and the entire Mirion team , and we are sustaining a vigilant posture toward the evolving challenges . Lastly , I'm very excited as we move forward with our enhanced capital structure following the business combination with GSAH . We expect this new structure will provide us with increased flexibility to drive internal and external stakeholder value by